Seizing Entrepreneurial Opportunities in Pudong: Embracing the Rise of Returnee Entrepreneurs
From November 9th to 11th, under the guidance of the United Front Work Department of the Shanghai Municipal Committee (Overseas Chinese Affairs Office of the Municipal Government), the “Overseas Chinese Innovation and Entrepreneurship Study Camp” (the 3rd Study Camp for Overseas Chinese Young Science and Technology Entrepreneurs and the 16th Study Camp for Overseas Chinese Returnees’ Entrepreneurship) was hosted by the United Front Work Department of the Pudong New Area Committee (Overseas Chinese Affairs Office of the District Government) and commenced in Zhangjiang. Focusing on the trend of overseas talent “returning” to China, the event aims to provide a platform for nurturing and fostering the innovation and entrepreneurship of young people in the overseas Chinese community who come to Shanghai, further strengthen exchanges with the new generation of overseas Chinese, and cultivate their patriotism and love for their hometown.
Meanwhile, Shanghai Television’s program “632 Observations” also conducted an interview with Kayla Yuan, a director at HB Ventures, to explore together the new opportunities being discovered by young overseas Chinese science and technology entrepreneurs.
Related Posts
” E-Tronic(Guangzhou) Technology” completes Series A financing led by Infinity Capital
E-Tronic(Guangzhou)Technology Co.，Ltd., a provider of power semiconductors and system solutions for new energy vehicles, has completed its Series A financing with a cumulative amount of over 100 million RMB. This round of financing was led by Infinity Capital, with additional investment from old shareholders Zhongnan Venture Capital and Guangzhou Development
Pillar Biosciences Partners with AstraZeneca to Accelerate Access to Liquid Biopsy Testing (September, 2024)
In September 2024, Pillar Biosciences announced a strategic partnership with AstraZeneca to expand laboratory access to molecular testing in Europe and the UK using rapid, affordable NGS-based liquid biopsy tumor profiling kits. The collaboration leverages Pillar’s oncoReveal™ liquid biopsy panels to deliver highly sensitive and specific tumor genetic varia
Connecting the Future: Web3Labs, IoTeX, and Goldford-HB Ventures Jointly Launch Global Recruitment for DePIN Project
Recently, Asia’s well-known Web3 accelerator Web3Labs officially announced that it will join forces with DePIN infrastructure leader IoTeX and venture capital firm Goldford-HB Ventures to launch a new round of global recruitment for DePIN projects. Committed to finding and cultivating project teams with innovative spirit and strong potential for joint investm
Pillar Biosciences Raises $34.5 Million to Accelerate Precision Medicine Innovation
In May 2025, Pillar Biosciences announced it had raised $34.5 million in funding, with participation from Illumina, Soleus Capital, and existing investors. The proceeds will be used to expand commercial activities, strengthen partnerships with biopharma companies, and accelerate the adoption of its distributable clinical testing kits worldwide. Pillar’s SLIMa